Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: Comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression (Q39899086)
scientific article published on February 19, 2010
Language:
(P31) (Q13442814)
(P304) 351-362
(P407) (Q1860)
(P433) 5
(P478) 38
(P577) Friday, February 19, 2010
(P921) (Q1427096)
(Q29496)
(Q72138716)
(P953) http://www.exphem.org/article/S0301472X10000512/pdf
https://api.elsevier.com/content/article/PII:S0301472X10000512?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0301472X10000512?httpAccept=text/plain
(P1433) (Q5421109)
(P1476) "Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression" (language: en)
"Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: Comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression" (language: en)
(P2093) Véronique Decot
Laure Voillard
Véronique Latger-Cannard
Lamia Aissi-Rothé
Pascale Perrier
Jean Francois Stoltz
Daniele Bensoussan
(P2860) (Q73023273)
other details
description scientific article published on February 19, 2010

External Links